Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Data from Poor Outcome in Estrogen Receptor–Positive Breast Cancers Predicted by Loss of <i>Plexin B1</i>

View through CrossRef
<div>Abstract<p><b>Purpose:</b> A common characteristic of mammary carcinomas is an inverse relationship between the estrogen receptor (ER) status and the proliferative activity of the tumor. Yet, a subset of ER-positive breast cancers is characterized by a high proliferation, suggesting malfunctions in ER responsiveness that influence the biological and therapeutic behavior of tumor cells. The expression of several ER-dependent genes seems to be dysregulated among those “uncoupled” tumors. One of those genes is <i>plexin B1</i>, a cell-surface receptor for the semaphorin Sema4D (CD 100). However, the biological role of plexin B1 in breast cancer is largely unknown.</p><p><b>Experimental Design:</b> Expression data of plexin B1 were obtained from Affymetrix microarray analysis of <i>n</i> = 119 breast cancer specimens. Validation was done by quantitative real-time PCR and protein expression was evaluated by immunohistochemistry. Expression data were compared with clinical characteristics as well as follow-up data of the disease.</p><p><b>Results:</b> Low plexin B1 expression levels characterize a more aggressive tumor phenotype. The expression of plexin B1 is strongly correlated with the ER status. However, even among ER-positive tumors, loss of plexin B1 is associated with an impaired prognosis of breast cancer patients in both univariate (all patients, <i>P</i> = 0.0062; ER positive, <i>P</i> = 0.0107) and multivariate analyses (all patients, <i>P</i> = 0.032; ER positive, <i>P</i> = 0.022). Immunohistochemistry reveals that the tumor cells themselves and not the endothelial cells are the major source of plexin B1 expression in the tumor.</p><p><b>Conclusion:</b> Plexin B1 acts not only as a new important prognostic but should also represent a predictive marker indicating an endocrine resistance. These data give a new insight in markers that could be involved in endocrine dysregulation of breast cancer.</p></div>
Title: Data from Poor Outcome in Estrogen Receptor–Positive Breast Cancers Predicted by Loss of <i>Plexin B1</i>
Description:
<div>Abstract<p><b>Purpose:</b> A common characteristic of mammary carcinomas is an inverse relationship between the estrogen receptor (ER) status and the proliferative activity of the tumor.
Yet, a subset of ER-positive breast cancers is characterized by a high proliferation, suggesting malfunctions in ER responsiveness that influence the biological and therapeutic behavior of tumor cells.
The expression of several ER-dependent genes seems to be dysregulated among those “uncoupled” tumors.
One of those genes is <i>plexin B1</i>, a cell-surface receptor for the semaphorin Sema4D (CD 100).
However, the biological role of plexin B1 in breast cancer is largely unknown.
</p><p><b>Experimental Design:</b> Expression data of plexin B1 were obtained from Affymetrix microarray analysis of <i>n</i> = 119 breast cancer specimens.
Validation was done by quantitative real-time PCR and protein expression was evaluated by immunohistochemistry.
Expression data were compared with clinical characteristics as well as follow-up data of the disease.
</p><p><b>Results:</b> Low plexin B1 expression levels characterize a more aggressive tumor phenotype.
The expression of plexin B1 is strongly correlated with the ER status.
However, even among ER-positive tumors, loss of plexin B1 is associated with an impaired prognosis of breast cancer patients in both univariate (all patients, <i>P</i> = 0.
0062; ER positive, <i>P</i> = 0.
0107) and multivariate analyses (all patients, <i>P</i> = 0.
032; ER positive, <i>P</i> = 0.
022).
Immunohistochemistry reveals that the tumor cells themselves and not the endothelial cells are the major source of plexin B1 expression in the tumor.
</p><p><b>Conclusion:</b> Plexin B1 acts not only as a new important prognostic but should also represent a predictive marker indicating an endocrine resistance.
These data give a new insight in markers that could be involved in endocrine dysregulation of breast cancer.
</p></div>.

Related Results

Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract Introduction Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...
Coexisting Granulomatous Mastitis and Breast Cancer: A Systematic Review
Coexisting Granulomatous Mastitis and Breast Cancer: A Systematic Review
Abstract Introduction: Granulomatous mastitis (GM) is a rare inflammatory breast disease that mimics carcinoma. GM can coexist with breast cancer (BC), though the relationship rema...
Desmoid-Type Fibromatosis of The Breast: A Case Series
Desmoid-Type Fibromatosis of The Breast: A Case Series
Abstract IntroductionDesmoid-type fibromatosis (DTF), also called aggressive fibromatosis, is a rare, benign, locally aggressive condition. Mammary DTF originates from fibroblasts ...
Plexin B2 tissue expression and related gene polymorphisms in psoriasis and their relation to NB-UVB and Acitretin therapy
Plexin B2 tissue expression and related gene polymorphisms in psoriasis and their relation to NB-UVB and Acitretin therapy
AbstractPsoriasis is a chronic, immune-mediated, hyperproliferative skin disease. Etiopathogenesis of psoriasis is not well understood. Plexin B2 was found to have effects on CD100...
Abstract 1807: Inter-individual variation in response to estrogen in the mammary gland
Abstract 1807: Inter-individual variation in response to estrogen in the mammary gland
Abstract Background: Previous research has highlighted the paradoxical nature of estrogen in both contributing to and reducing the risk of breast cancer. Exposure to...
Abstract 1201: Role of the chemokine CXCL12 in the estrogen response of breast cancer cells
Abstract 1201: Role of the chemokine CXCL12 in the estrogen response of breast cancer cells
Abstract The purpose of this study was to investigate the extent to which CXCL12 mediates the effects of estrogen in estrogen-responsive breast cancer cells. Express...
Data from Plexin-B1 Mutation Drives Metastasis in Prostate Cancer Mouse Models
Data from Plexin-B1 Mutation Drives Metastasis in Prostate Cancer Mouse Models
<div><p>Metastatic prostate cancer is essentially incurable and is a leading cause of cancer-related morbidity and mortality in men, yet the underlying molecular mechan...
Essential roles of plexin-B3+ oligodendrocyte precursor cells in the pathogenesis of Alzheimer’s disease
Essential roles of plexin-B3+ oligodendrocyte precursor cells in the pathogenesis of Alzheimer’s disease
AbstractThe role of oligodendrocyte lineage cells, the largest glial population in the adult central nervous system (CNS), in the pathogenesis of Alzheimer’s disease (AD) remains e...

Back to Top